Paclitaxel, Cisplatin and Methotrexate Combination Chemotherapy is Active in the Treatment of Refractory Urothelial Malignancies

The Journal of Urology

Volumn 154, Issue 5, 1995, Pages 1719-1722

  Tu, Shi Ming ^a   Hossan, Elizabeth ^a   Amato, Robert ^a   Kilbourn, Robert ^a   Logothetis, Christopher J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; METHOTREXATE; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DEMENTIA; DIARRHEA; DRUG INDUCED DISEASE; DRUG RESPONSE; FEMALE; HEART INFARCTION; HUMAN; MALE; METASTASIS; NEPHROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; SENSORY NEUROPATHY; THROMBOCYTOPENIA; UROGENITAL TRACT CANCER;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLADDER NEOPLASMS; CISPLATIN; FEMALE; HUMAN; MALE; METHOTREXATE; MIDDLE AGE; PACLITAXEL; PILOT PROJECTS;

EID: 0028877082     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66765-X     Document Type: Article

References (15)

1. Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract: a Northern California Oncology Group study
2. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium
3. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study
4. Second-line M-VAC therapy in patients previously treated with the M-VAC regimen for metastatic urothelial cancer
5. Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors
6. Treatment of advanced transitional cell carcinoma of the bladder with continuous-infusion gallium nitrate
7. Fluorouracil and recombinant human interferon alfa-2a in the treatment of metastatic chemotherapy-refractory urothelial tumors
8. Paclitaxel in previously untreated, advanced transitional cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group (ECOG)
9. Biweekly paclitaxel and cisplatin in the treatment of metastatic breast cancer
10. Phase II trial of paclitaxel and cisplatin in women with metastatic breast cancer
11. Paclitaxel plus cisplatin in non small cell lung cancer: a dose finding study
12. Escalated MVAC +/− rhGM-CSF (Schering-Plough) in metastatic transitional cell carcinoma: preliminary results of a randomized trial
13. Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine
14. Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro
15. Sequences of taxol and cisplatin: a phase I and pharmacologic study